جستجوی استاد راهنمای دانشگاهی

• Immunology
• Vaccinology
• Malaria Research
• +۴ مورد دیگر

Cyrielle Elyette Fougeroux serves as a Postdoctoral Researcher at the Department of Immunology and Microbiology within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her research focuses on adenovirus vaccine platforms, malaria immunization strategies, and novel adjuvant development. She maintains active collaborations with international institutions including University Medical Center Freiburg, Sirion Biotech, and GSK, with her work on cVLP-based vaccines leading to patent development. Education: PhD in Immunology and Infectious Diseases (2014-2017), Center for Medical Parasitology, University of Copenhagen Master in Immunology (2011-2013), Pasteur Institute Immunology Advanced Program, Paris Bachelor in Physiology, Cellular and Molecular Biology (2009-2011), Paris Dr. Fougeroux's research centers on molecular mechanisms of immune responses against extracellular pathogens, with emphasis on adenovirus vectors for malaria vaccination and novel adjuvant systems. Her work bridges basic immunology and translational vaccine development, particularly investigating the EPCR-binding domains of PfEMP1 for malaria and capsid virus-like particles for SARS-CoV-2 and cancer applications. She has developed freeze-drying techniques enabling ambient-temperature vaccine storage, addressing critical distribution challenges in resource-limited settings. Analysis of her 17 publications reveals strong focus on capsid virus-like particle platforms across multiple disease targets. Her work demonstrates consistent innovation in vaccine vector design, with recent expansion into therapeutic cancer vaccines. The research shows progression from basic vector development (2022) to clinical translation (2023 Lancet Microbe paper) and novel applications in oncology (2025 publication), maintaining strong emphasis on molecular immunology mechanisms throughout. Scientific Recognition: Award for best presentation at Young Researcher Forum, Eurovaccine Conference, Paris Dr. Fougeroux actively supervises early-career researchers, having mentored 2 lab technician trainees, 1 medical student, 2 master's students, and 1 bachelor's student during her postdoctoral tenure. She manages laboratory operations including weekly group meetings, database creation, and standard operating protocols. Her international collaborations span Danish, German, and French institutions, with notable partnerships including the COUGH-1 trial study group and University Medical Center Freiburg. Current research includes adenovirus vaccine strategies, adjuvant development for extracellular pathogens, and malaria vaccine requirements evaluation.

• Neuroscience
• Motor Control
• Neural Circuits
• +۵ مورد دیگر

Ole Kiehn is a Professor in Integrative Neuroscience at the Department of Neuroscience, University of Copenhagen, Denmark, and concurrently serves as Professor in Neuroscience at the Department of Neuroscience, Karolinska Institute, Sweden. His research focuses on understanding the neuronal networks that produce movements, which are the origin of all behaviors. Education: MD from University of Copenhagen, Denmark (1985) D.Sci from University of Copenhagen, Denmark (1990) Docent, Karolinska Institutet, Sweden (2002) Kiehn's research centers on the molecular, cellular, and network diversification of locomotor circuitries in mammals. His lab applies advanced physiological and molecular genetic approaches including optogenetics, RNA-seq, molecular tracing, advanced imaging, and electrophysiology to study spinal and brainstem circuits. They have deciphered the functional organization of spinal circuitries for locomotion timing and coordination, and delineated brainstem circuits involved in gating or context-dependent selection of motor behaviors. Current research also investigates plasticity in spinal networks following spinal cord injury and the role of spinal interneurons in amyotrophic lateral sclerosis (ALS). Analysis of Kiehn's recent publications reveals a strong focus on neural circuit mechanisms underlying locomotion and behavior. His work spans multiple levels from molecular and cellular mechanisms to network organization and behavioral outcomes. Key themes include spinal cord circuitry, brainstem control of movement, neuromodulation, neurodegeneration in ALS, and the integration of different brain regions for coordinated motor behavior. The research demonstrates significant translational potential for developing therapies for movement disorders caused by trauma or disease. Scientific Awards and Honors: Lundbeck Foundation's Professorship award (2019-) Novo Nordic Foundation Laureate program (2017-) European Research Council advanced grant (2016-, second award) Member of EMBO (2014) Member of Academia Europea (2013) Member of the Royal Swedish Academy of Sciences (2012) Member of The Royal Danish Academy of Sciences and Letters (2010) Torsten and Ragnar Söderberg's Professorship (2011-2016) European Research Council advanced grant (2011-2016) 5 Year Distinguished Professor Award from Karolinska Institute (2010-2015) Schellenberg Prize in spinal cord research (2004) Kiehn has supervised more than 10 PhD students and 25 postdocs throughout his career, hosting guest professors from institutions including Cornell University, Salk Institute, Oslo University, and William and Mary. His lab has secured substantial funding including Lundbeck Foundation's Professorship Grant (32 MDKK, 2020-2026), Novo Nordic Foundation Laureate Program (40 MDKK, 2017-2023), and multiple European Research Council advanced grants. He has served as PI for major collaborative projects including an NIH R01 grant with researchers from Drexel University and Salk Institute. Kiehn leads a research group focused on integrative neuroscience with expertise in advanced physiological and molecular genetic approaches. His lab bridges the gap between neuronal circuit organization and behavior, with strong translational potential for developing therapies for movement disorders. He also serves as Co-editor in chief of Current Opinion in Neurobiology and has held significant leadership roles including Vice Chair of the Nobel Committee for Physiology or Medicine (2016) and member of the Nobel Committee (2014-2019).

Saahil Sandeep Baghelمشاهده پروفایل

پژوهشگر ارشد

• mRNA vaccine delivery
• Lipid nanoparticles
• Nanomedicine
• +۴ مورد دیگر

Saahil Sandeep Baghel is a PhD fellow in Pharmaceutical Sciences at the Department of Pharmacy, University of Copenhagen, affiliated with the LEO Foundation Center for Cutaneous Drug Delivery. His research focuses on advanced drug delivery systems with emphasis on mRNA vaccines and nanomedicine applications. His educational background includes: MSc in Pharmaceutical Sciences (2020-2022) from University of Copenhagen, specializing in Development and Optimization of messenger RNA loaded Lipidoid-Polymer hybrid nanoparticles Bachelor of Pharmacy (2016-2020) from University of Copenhagen Baghel's research spans multiple cutting-edge areas in pharmaceutical sciences, with particular expertise in lipid nanoparticle formulations for mRNA delivery. His work addresses critical challenges in vaccine development, particularly for infectious diseases like malaria, and explores novel applications in dermatological and respiratory drug delivery. His research integrates nanotechnology with pharmaceutical formulation to enhance therapeutic efficacy and target specificity. Analysis of his publication record reveals a strong focus on mRNA vaccine platforms (40% of recent work), lipid nanoparticle optimization (30%), and specialized drug delivery systems for dermatological and respiratory applications (20%). His 2025 publications in Nature Nanotechnology and Advanced Functional Materials demonstrate significant contributions to replacing cholesterol in mRNA-LNPs and developing modular vaccine platforms. The consistent citation metrics (up to 62 Mendeley readers) and media coverage (19 news outlets for key publications) indicate substantial impact in the field. Baghel collaborates extensively with researchers across multiple institutions, particularly within the LEO Foundation Center for Cutaneous Drug Delivery. His work has generated notable scientific attention, with several publications referenced in patents and widely shared across social media platforms including X (formerly Twitter) and Bluesky. The interdisciplinary nature of his research bridges pharmaceutical technology, vaccinology, and nanomedicine to address complex therapeutic challenges.

• Immunology
• Vaccine Development
• Microbiology
• +۳ مورد دیگر

Sayit Mahmut Erdogan serves as an Assistant Professor in the Department of Immunology and Microbiology at the University of Copenhagen, affiliated with the Centre for Medical Parasitology (CMP) and BIVAC. His research focuses on developing novel vaccine platforms against infectious diseases, with laboratory access at Blegdamsvej 3B, 2200 København N, and contactable via phone (+4535331653) or email (sayit.erdogan@sund.ku.dk). His core research interests include: Vaccine design using modular capsid and virus-like particle platforms Neutralizing antibody induction against viral pathogens like SARS-CoV-2 Bispecific immune engagers for malaria therapeutics Translational immunology bridging basic research and clinical applications Parasite-host immune interactions in infectious disease contexts Analysis of his publication record reveals a strong emphasis on rapid-response vaccinology for emerging pathogens. The 2023 Lancet Microbe trial demonstrated the first-in-human application of a modular capsid platform for SARS-CoV-2, while the 2021 Nature Communications study showed how receptor-binding domain decoration enhances viral neutralization. His Cell Death & Disease work extended these principles to malaria, indicating cross-disease applicability of his platform technologies. Collectively, these publications exhibit a consistent focus on innovative antigen presentation systems for infectious disease prevention. Dr. Erdogan operates within the Centre for Medical Parasitology (CMP) and BIVAC collaborative networks, engaging in multidisciplinary research that integrates structural biology, immunology, and clinical translation. His work has generated significant external attention, including coverage by 31 news outlets, 3 blog posts, 42 social media mentions, and 7 patent references across his publications.

Claus Cornettمشاهده پروفایل

دانشیار

• NMR Spectroscopy
• Drug Metabolism
• Pharmaceutical Spectroscopy
• +۵ مورد دیگر

Claus Cornett is an Associate Professor in the Department of Pharmacy at the Faculty of Pharmaceutical Sciences, University of Copenhagen. He has been serving in this role since 1992 and maintains an active research program in pharmaceutical analytical chemistry. His educational background includes a Master of Science in Chemistry from 1986 and a PhD (Pharm) from 1992. Prior to his current position, he served as an Assistant Professor at the Department of Organic Chemistry at The Pharmaceutical University of Denmark starting in 1988. Professor Cornett's research focuses on advanced analytical techniques, particularly NMR spectroscopy applications in pharmaceutical analysis. His primary research areas include structure elucidation of small molecules and drug metabolites, hyphenation of NMR with other analytical techniques (HPLC, CZE, MS), flow injection NMR, and chemometric methods for data processing. He has made significant contributions to near-infrared imaging of pharmaceutical products and medicinal cannabis research. His recent publications (2021-2025) demonstrate a strong focus on pharmaceutical analytical methods, with particular emphasis on patient-tailored drug products, antidepressant medications, and cannabis-based therapeutics. These works span analytical chemistry, pharmaceutical technology, and clinical pharmacology, showing interdisciplinary applications of his core expertise in spectroscopic methods. Professor Cornett has served as a reviewer and editorial board member for numerous prestigious journals including Journal of Pharmaceutical Analysis, Journal of Proteome Research, and Phytochemical Analysis, demonstrating his standing in the scientific community. His teaching portfolio includes Instrumental Analytical Chemistry, Advanced Analytical Chemistry, and Choice and Validation of Analytical Methods. He has also assessed qualifications for multiple assistant and associate professor positions at his institution.

• Ecology
• Evolutionary Biology
• Mutualistic Interactions
• +۳ مورد دیگر

Maximilian Vollstädt is a Postdoctoral Researcher and Guest Researcher at the Globe Institute, University of Copenhagen, specifically within the Section for Molecular Ecology and Evolution. His research focuses on ecological and evolutionary processes, particularly in island ecosystems and species interactions. Dr. Vollstädt's research interests span several key areas in ecology and evolution: Mutualistic interactions between plants and animals Island biogeography and insularity effects on ecosystems Avian frugivory and plant-pollinator networks Ecological network analysis and community assembly Impacts of environmental change on species interactions His recent publications demonstrate a strong focus on Caribbean island ecosystems, examining how hummingbirds interact with plants, how birds optimize fruit consumption near range limits, and how ecological boundaries affect species interactions. Vollstädt frequently employs network analysis approaches to understand complex ecological relationships and has published in high-impact journals including Science, Nature Communications, and Functional Ecology. Dr. Vollstädt collaborates extensively with researchers across the globe, with particular connections to researchers studying Caribbean and island ecosystems. His work has received attention from multiple news outlets and social media platforms, indicating its relevance to broader scientific and public audiences.

• Structural Biology
• Protein Production
• NMR Spectroscopy
• +۵ مورد دیگر

Robert Dagil is an Assistant Professor in the Department of Immunology and Microbiology at the University of Copenhagen's Faculty of Health and Medical Sciences. He is a member of the VAR2CSA research team and maintains an active research profile with numerous recent publications in high-impact journals. Education: Ph.D in Structural Biology and NMR Laboratory, Department of Biology, University of Copenhagen (2013) M.Sc. in Chemistry, Department of Chemistry, University of Copenhagen (2008) Dr. Dagil's research focuses on protein structure-function relationships, with particular expertise in NMR spectroscopy, crystallography, and protein production techniques. His work has evolved from fundamental structural biology to translational applications in both infectious disease and oncology. He specializes in protein production, conjugation experiments, and development of upstream/downstream processes for recombinant proteins. His recent work demonstrates a significant shift toward cancer immunotherapy, particularly targeting oncofetal chondroitin sulfate for tumor detection and therapy development. Analysis of his recent publications (2023-2025) reveals a strong emphasis on developing novel cancer therapies through antibody targeting of specific glycosaminoglycans. His work spans multiple high-impact areas including multi-cancer detection methods, CAR T-cell therapies, bispecific T-cell engagers, and tumor-agnostic therapeutic approaches. While maintaining connections to infectious disease research (particularly malaria and SARS-CoV-2), his primary focus has shifted toward oncology applications with several publications in Nature Communications, The Lancet Microbe, and other prestigious journals. Dr. Dagil is actively involved in multiple collaborative research projects, particularly within the VAR2CSA team at the University of Copenhagen, where he contributes expertise in protein production and structural analysis. His work bridges fundamental protein science with clinical applications, demonstrating a strong translational research approach.